Skip to main content
. 2017 Feb 21;8(15):24635–24643. doi: 10.18632/oncotarget.15601

Table 1. In vitro anti-tumor activity of IMB-1406 and sunitinib against four cell lines.

Cell lines Inhibition rate (30 μM) IC50 (μM)
IMB-1406 Sunitinib IMB-1406 Sunitinib
A549 100.07% 100.02% 8.99 10.36
HepG2 99.98% 98.61% 6.92 7.60
DU145 99.93% 86.51% 7.89 7.99
MCF7 100.39% 88.89% 8.26 8.65